Table 3. Early postoperative laboratory values and hemodynamic data.
| Variables | SherpaPak™ (n=7) | Standard technique (n=14) | P value |
|---|---|---|---|
| CK-MB baseline | 123.19±40.77 | 134.34±69.52 | 0.703 |
| CK-MB 24 h after transplant | 101.20±67.11 | 119.85±112.5 | 0.702 |
| AST baseline | 165.53±102.92 | 374.84±673.02 | 0.429 |
| AST 6 h after transplant | 248.36±213.12 | 486.59±682.43 | 0.384 |
| ALT baseline | 48.52±40.11 | 108.04±240.97 | 0.529 |
| ALT 6 h after transplant | 83.11±83.27 | 199.66±367.20 | 0.423 |
| VIS Score baseline | 44.01±22.91 | 62.97±47.87 | 0.338 |
| VIS Score 24 h after transplant | 19.48±11.34 | 18.46±14.26 | 0.871 |
| Enoximone (µg/kg/min) | 1.79±0.62 | 2.16±0.69 | 0.254 |
| Norepinephrine (µg/kg/min) | 0.37±0.21 | 0.57±0.047 | 0.318 |
| Lactate arterial | 5.24±3.00 | 6.14±5.62 | 0.702 |
| Lactate venous | 5.43±3.15 | 5.97±5.27 | 0.805 |
| Cardiac Index (L/min/m2) | 2.65±0.26 | 2.53±0.56 | 0.702 |
| Mixed venous saturation (%) | 69.41±7.03 | 67.49±10.61 | 0.674 |
| Central venous pressure (mmHg) | 13±5.03 | 12.54±4.39 | 0.833 |
| Wedge pressure (mmHg) | 11.43±5.593 | 12.42±4.39 | 0.677 |
| Time on respirator (min) | 39.70±27.90 | 42.42±35.39 | 0.881 |
| Defibrillated after de-clamping | 2 (28.6%) | 3 (21.4%) | 0.717 |
| VA-ECMO after transplant | 2 (28.6%) | 2 (14.3%) | 0.432 |
| Positive blood cultures | 0 (0%) | 4 (28.6%) | 0.255 |
CK-MB, creatine kinase muscle-brain type; AST, aspartate transaminase; ALT, alanine transaminase; VIS Score, Vasoactive-inotropic Score; VA-ECMO, veno-arterial Extracorporeal membrane oxygenation.